Developing a novel, blood-based test
for enhancing cardiac catheterization rule in/rule out
Update: Research paper on Prevencio's biomarker technology published in BioMed Medicine.
Prevencio® is the registered trademark of Prevencio, Inc., a Delaware Corporation. Copyright (2013). All rights reserved. Diagnostic products described here are not for sale and have not been cleared by the FDA for commercial sale.
The HART™ blood-based test helps differentiate chest pain patients who have obstructive heart disease and need more extensive testing from those patients who can be safely sent home.